Nuvilex has entered into a Joint Venture Agreement with Legacy Biotechnologies to develop and market all natural remedies for symptoms of broad spectrum flu viruses. Reportedly, as part
Humco Holding Group (Humco) has reported that it is increasing inventories and production capabilities of Humco Cherry Syrup for use in the emergency compounding of an oral suspension
aTyr Pharma has reported that the US Patent office has issued patent US no 7572452 B2, titled ‘Method for Stimulating Wound Healing’. Reportedly, this patent covers new extracellular
The National Institutes of Health (NIH) has awarded a $2.87m grant to Ceragenix Pharmaceuticals to fund the pre clinical development of a Ceragenin based oral drug to treat
Oramed Pharmaceticals has received approval from the Institutional Review Board (IRB) to commence human clinical trials of an oral GLP-1 Analog. The approval was granted after successful pre-clinical
ChemGenex Pharmaceuticals (ChemGenex ) has submitted its New Drug Application (NDA) to the FDA for Omapro (omacetaxine mepesuccinate). Omapro is being developed for the treatment of patients with
Almirall has reported its intention to file a Marketing Authorization Application (MAA) with the European Medicines Agency (EMEA) for muscarinic antagonist Eklira (aclidinium bromide) in early 2010, for
Alnylam has reported that the European Patent Office (EPO) has issued a notification of intent to grant for a patent in the Kreutzer-Limmer III patent series (EP Application
Affymax has reported that it has informed clinical trial sites to complete treatment of patients in the phase 3 clinical program for the investigational drug, Hematide, by the
Anadys Pharmaceuticals (Anadys) has reported first dosing in a phase II trial of ANA598 in patients chronically infected with hepatitis C virus (HCV). Reportedly, the study will evaluate
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.